| 1 |
Zhang X, He C, He X, Fan S, Ding B, Lu Y, Xiang G. HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy. J Control Release 2023;356:649-62. [PMID: 36933701 DOI: 10.1016/j.jconrel.2023.03.026] [Reference Citation Analysis]
|
| 2 |
Yang Z, Wang S, Hong Y, Gai R, Hong W, Tang B, Lin C, Wang X, Wang Q, Chen C, Wang J, Weng Q. Safety Evaluation of Curcumol by a Repeated Dose 28-Day Oral Exposure Toxicity Study in Rats. Toxics 2023;11. [PMID: 36850989 DOI: 10.3390/toxics11020114] [Reference Citation Analysis]
|
| 3 |
Cui L, Zeng Z, Wang X, Yuan T, Wang C, Liu D, Guo J, Chen Y. Deciphering the Mechanism of Wogonin, a Natural Flavonoid, on the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Integrating Network Pharmacology and In Vitro Validation. Curr Issues Mol Biol 2023;45:555-70. [PMID: 36661523 DOI: 10.3390/cimb45010037] [Reference Citation Analysis]
|
| 4 |
Li Y, Li H, He Q, Yang X. Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review. Molecules 2022;28. [PMID: 36615387 DOI: 10.3390/molecules28010195] [Reference Citation Analysis]
|
| 5 |
Sin SQ, Mohan CD, Goh RMW, You M, Nayak SC, Chen L, Sethi G, Rangappa KS, Wang L. Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities. Cancer Metastasis Rev 2022. [DOI: 10.1007/s10555-022-10071-1] [Reference Citation Analysis]
|
| 6 |
Yang Z, Sun Q, Wang S, Tang B, Yuan C, Wu Y, Dai J, Yang C, Wang L, Zhou Q, Wang J, Weng Q. Pharmacokinetics, tissue distribution, and plasma protein binding rate of curcumol in rats using liquid chromatography tandem mass spectrometry. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1036732] [Reference Citation Analysis]
|
| 7 |
Ma C, Tang X, Tang Q, Wang S, Zhang J, Lu Y, Wu J, Han L. Curcumol repressed cell proliferation and angiogenesis via SP1/mir-125b-5p/VEGFA axis in non-small cell lung cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1044115] [Reference Citation Analysis]
|
| 8 |
Chun KS, Kim DH, Raut PK, Surh YJ. Anticancer natural products targeting immune checkpoint protein network. Semin Cancer Biol 2022;86:1008-32. [PMID: 34838956 DOI: 10.1016/j.semcancer.2021.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Zhang Z, Hu Y, Chen Y, Chen Z, Zhu Y, Chen M, Xia J, Sun Y, Xu W. Immunometabolism in the tumor microenvironment and its related research progress. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1024789] [Reference Citation Analysis]
|
| 10 |
Liu K, Sun Q, Liu Q, Li H, Zhang W, Sun C. Focus on immune checkpoint PD-1/PD-L1 pathway: New advances of polyphenol phytochemicals in tumor immunotherapy. Biomedicine & Pharmacotherapy 2022;154:113618. [DOI: 10.1016/j.biopha.2022.113618] [Reference Citation Analysis]
|
| 11 |
Sheng W, Ding J, Liu L, Wang N, Lu B, You X, He Q, Zhou Q, Lin H. Curcumol Inhibits the Development of Prostate Cancer by miR-125a/STAT3 Axis. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-16. [DOI: 10.1155/2022/9317402] [Reference Citation Analysis]
|
| 12 |
Wang J, Jin J, Chen T, Zhou Q. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages. Molecules 2022;27:4345. [DOI: 10.3390/molecules27144345] [Reference Citation Analysis]
|
| 13 |
Zhang M, Shen W, Jiang Q, Sun Q, Liu Y, Yang Y, Yin D. Engineering a curcumol-loaded porphyrinic metal-organic framework for enhanced cancer photodynamic therapy. Colloids Surf B Biointerfaces 2022;214:112456. [PMID: 35290822 DOI: 10.1016/j.colsurfb.2022.112456] [Reference Citation Analysis]
|
| 14 |
Sun S, Huan S, Li Z, Yao Y, Su Y, Xia S, Wang S, Xu X, Shao J, Zhang Z, Zhang F, Fu J, Zheng S. Curcumol alleviates liver fibrosis by inducing endoplasmic reticulum stress-mediated necroptosis of hepatic stellate cells through Sirt1/NICD pathway. PeerJ 2022;10:e13376. [PMID: 35582617 DOI: 10.7717/peerj.13376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Liu C, Zhong WL. Curcumol Targeting PAX8 Inhibits Ovarian Cancer Cell Migration and Invasion and Increases Chemotherapy Sensitivity of Niraparib. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/3941630] [Reference Citation Analysis]
|
| 16 |
Wang JY, Xing Y, Li MY, Zhang ZH, Jin HL, Ma J, Lee JJ, Zhong Y, Zuo HX, Jin X. Panaxadiol inhibits IL-1β secretion by suppressing zinc finger protein 91-regulated activation of non-canonical caspase-8 inflammasome and MAPKs in macrophages. J Ethnopharmacol 2022;283:114715. [PMID: 34648898 DOI: 10.1016/j.jep.2021.114715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Schulz D, Wetzel M, Eichberger J, Piendl G, Brockhoff G, Wege AK, Reichert TE, Ettl T, Bauer RJ. Differential Expression of PD-L1 during Cell Cycle Progression of Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2021;22:13087. [PMID: 34884892 DOI: 10.3390/ijms222313087] [Reference Citation Analysis]
|
| 18 |
Mortezaee K, Majidpoor J. The impact of hypoxia on immune state in cancer. Life Sci 2021;286:120057. [PMID: 34662552 DOI: 10.1016/j.lfs.2021.120057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 19 |
Wang JY, Jiang MW, Li MY, Zhang ZH, Xing Y, Ri M, Jin CH, Xu GH, Piao LX, Jin HL, Ma J, Zuo HX, Jin X. Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation. J Nutr Biochem 2021;:108899. [PMID: 34748924 DOI: 10.1016/j.jnutbio.2021.108899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Lv X, Sun J, Hu L, Qian Y, Fan C, Tian N. Curcumol inhibits malignant biological behaviors and TMZ-resistance in glioma cells by inhibiting long noncoding RNA FOXD2-As1-promoted EZH2 activation. Aging (Albany NY) 2021;13:24101-16. [PMID: 34739394 DOI: 10.18632/aging.203662] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 21 |
Sheng W, Xu W, Ding J, Li L, You X, Wu Y, He Q. Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9. Oncol Rep 2021;46:246. [PMID: 34590156 DOI: 10.3892/or.2021.8197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Tanaka C, Kobori T, Tameishi M, Urashima Y, Ito T, Obata T. Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells. Molecules 2021;26:5648. [PMID: 34577118 DOI: 10.3390/molecules26185648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 23 |
Yun BD, Son SW, Choi SY, Kuh HJ, Oh TJ, Park JK. Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha. Int J Mol Sci 2021;22:9819. [PMID: 34575983 DOI: 10.3390/ijms22189819] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 24 |
Guan X, Yu D, HuangFu M, Huang Z, Dou T, Liu Y, Zhou L, Li X, Wang L, Liu H, Wang J, Chen X. Curcumol inhibits EBV-positive Nasopharyngeal carcinoma migration and invasion by targeting nucleolin. Biochem Pharmacol 2021;192:114742. [PMID: 34428442 DOI: 10.1016/j.bcp.2021.114742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 25 |
Lv M, Shao J, Jiang F, Liu J. Curcumol may alleviate psoriasis-like inflammation by inhibiting keratinocyte proliferation and inflammatory gene expression via JAK1/STAT3 signaling. Aging (Albany NY) 2021;13:18392-403. [PMID: 34314383 DOI: 10.18632/aging.203287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 26 |
Ri MH, Ma J, Jin X. Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer. J Ethnopharmacol 2021;281:114370. [PMID: 34214644 DOI: 10.1016/j.jep.2021.114370] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 27 |
Yang B, Peng F, Zhang Y, Wang X, Wang S, Zheng Y, Zhang J, Zeng Y, Wang N, Peng C, Wang Z. Aiduqing formula suppresses breast cancer metastasis via inhibiting CXCL1-mediated autophagy. Phytomedicine 2021;90:153628. [PMID: 34247114 DOI: 10.1016/j.phymed.2021.153628] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Ding ZN, Dong ZR, Chen ZQ, Yang YF, Yan LJ, Li HC, Liu KX, Yao CY, Yan YC, Yang CC, Li T. Effects of hypoxia-inducible factor-1α and hypoxia-inducible factor-2α overexpression on hepatocellular carcinoma survival: A systematic review with meta-analysis. J Gastroenterol Hepatol 2021;36:1487-96. [PMID: 33393670 DOI: 10.1111/jgh.15395] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 29 |
Hu D, Gao J, Yang X, Liang Y. A Comprehensive Mini-Review of Curcumae Radix: Ethnopharmacology, Phytochemistry, and Pharmacology. Natural Product Communications 2021;16:1934578X2110206. [DOI: 10.1177/1934578x211020628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 30 |
Yan Guo F, Ji Zheng C, Wang M, Ai J, Ying Han L, Yang L, Fang Lu Y, Xuan Yang Y, Guan Piao M, Piao HR, Jin CM, Jin CH. Synthesis and Antimicrobial Activity Evaluation of Imidazole-Fused Imidazo[2,1-b][1,3,4]thiadiazole Analogues. ChemMedChem 2021;16:2354-65. [PMID: 33738962 DOI: 10.1002/cmdc.202100122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 31 |
Mirzaei S, Zarrabi A, Hashemi F, Zabolian A, Saleki H, Ranjbar A, Seyed Saleh SH, Bagherian M, Sharifzadeh SO, Hushmandi K, Liskova A, Kubatka P, Makvandi P, Tergaonkar V, Kumar AP, Ashrafizadeh M, Sethi G. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis? Cancer Lett 2021;509:63-80. [PMID: 33838282 DOI: 10.1016/j.canlet.2021.03.025] [Cited by in Crossref: 99] [Cited by in F6Publishing: 83] [Article Influence: 49.5] [Reference Citation Analysis]
|
| 32 |
Liu X, Xing Y, Li M, Zhang Z, Wang J, Ri M, Jin C, Xu G, Piao L, Jin H, Zuo H, Ma J, Jin X. Licochalcone A inhibits proliferation and promotes apoptosis of colon cancer cell by targeting programmed cell death-ligand 1 via the NF-κB and Ras/Raf/MEK pathways. J Ethnopharmacol 2021;273:113989. [PMID: 33677006 DOI: 10.1016/j.jep.2021.113989] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 33 |
Zhang YF, Zhang ZH, Li MY, Wang JY, Xing Y, Ri M, Jin CH, Xu GH, Piao LX, Zuo HX, Jin HL, Ma J, Jin X. Britannin stabilizes T cell activity and inhibits proliferation and angiogenesis by targeting PD-L1 via abrogation of the crosstalk between Myc and HIF-1α in cancer. Phytomedicine 2021;81:153425. [PMID: 33310309 DOI: 10.1016/j.phymed.2020.153425] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 34 |
Mun H, Townley HE. Nanoencapsulation of Plant Volatile Organic Compounds to Improve Their Biological Activities. Planta Med 2021;87:236-51. [PMID: 33176380 DOI: 10.1055/a-1289-4505] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 35 |
Di Martile M, Garzoli S, Ragno R, Del Bufalo D. Essential Oils and Their Main Chemical Components: The Past 20 Years of Preclinical Studies in Melanoma. Cancers (Basel) 2020;12:E2650. [PMID: 32948083 DOI: 10.3390/cancers12092650] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 36 |
Li P, Ge D, Li P, Hu F, Chu J, Chen X, Song W, Wang A, Tian G, Gu X. CXXC finger protein 4 inhibits the CDK18-ERK1/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1/MIR100HG pathway. J Cell Mol Med 2020;24:10151-65. [PMID: 32715641 DOI: 10.1111/jcmm.15625] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
|
